Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy.


Journal Article

Data were evaluated for patients with acute ST-elevation myocardial infarction (n = 94,182) enrolled in 6 large clinical trials evaluating the efficacy of various reperfusion strategies. It was found that compared with the tallest quartile, incidences of in-hospital reinfarction, stroke, major bleeding, cardiogenic shock, heart failure, and death in the shortest group were 1.4, 1.7, 1.7, 1.8, 1.9, and 2.4 times greater, respectively. Although a strong inverse association of height was observed with unadjusted 30-day mortality (p <0.001), it was attenuated after adjustment for confounders, including weight, and appeared to be nonlinear, such that for height 165 cm, the OR for a 10-cm increase in height was 0.962 (95% CI 0.896 to 1.033). These data indicate that height-related differences in 30-day mortality are explained in large part by height-related differences in patients' clinical characteristics.

Full Text

Duke Authors

Cited Authors

  • Mehta, RH; Califf, RM; Garg, J; Pieper, KS; Alexander, JH; Moliterno, DJ; Van de Werf, F; Ohman, EM; White, HD; Topol, EJ; Granger, CB

Published Date

  • June 1, 2005

Published In

Volume / Issue

  • 95 / 11

Start / End Page

  • 1371 - 1375

PubMed ID

  • 15904648

Pubmed Central ID

  • 15904648

International Standard Serial Number (ISSN)

  • 0002-9149

Digital Object Identifier (DOI)

  • 10.1016/j.amjcard.2005.01.087


  • eng

Conference Location

  • United States